TNFRSF25 agonistic antibody and galectin-9 combination therapy controls herpes simplex virus-induced immunoinflammatory lesions
about
Immunological aspects of acute and recurrent herpes simplex keratitisAn approach to control relapse of inflammatory lesions after discontinuation of primary therapyMatricellular proteins in the trabecular meshwork: review and update.IL-2/anti-IL-2 antibody complex treatment inhibits the development but not the progression of herpetic stromal keratitis.IL-17A-mediated protection against Acanthamoeba keratitis.On the role of regulatory T cells during viral-induced inflammatory lesions.Role of regulatory T cells during virus infection.Controlling herpetic stromal keratitis by modulating lymphotoxin-alpha-mediated inflammatory pathways.Immunobiology of TNFSF15 and TNFRSF25.Galectin-9: From cell biology to complex disease dynamics.Azacytidine Treatment Inhibits the Progression of Herpes Stromal Keratitis by Enhancing Regulatory T Cell Function.Translational Implication of Galectin-9 in the Pathogenesis and Treatment of Viral Infection.Regulatory T Cell-Mediated Suppression of Inflammation Induced by DR3 Signaling Is Dependent on Galectin-9.Death Receptor 3 Signaling Controls the Balance between Regulatory and Effector Lymphocytes in SAMP1/YitFc Mice with Crohn's Disease-Like Ileitis.
P2860
Q27016103-7C5E4934-A3C5-40A2-9F2F-EB19E0A08CD4Q28538993-484582A9-EB53-4BDF-B81C-C5E0331A935CQ33820048-E6324E60-4126-4608-99F8-24465E6F2B11Q34749483-AA654054-6A75-4D5B-BD86-1F2CE1A461D7Q34810412-C9817E9C-F461-4A7A-BCB1-D66CF137695BQ36457248-ABBD3639-B63E-47FB-966D-2F2A82240E2AQ37107677-22368004-0EFB-44FB-AC88-F7DE3606A374Q37161210-1CD22A0F-868E-4E21-8BF9-01F4C4947EC0Q38163429-58392AEE-0E15-41F5-AACD-E517FE14AFA3Q38942909-3D15FE6C-ED12-4ACD-87DE-3BDDA3AC6E8CQ40366439-3DFFC846-FBB6-4814-8202-975C3F12E178Q41921662-D578CEA9-975D-44DC-A2E5-35C79CC29F4DQ44000801-A66765A4-1B4A-4627-958D-E74457A01591Q51739535-2E65A2A5-E1E5-4D54-905A-29B778DED75A
P2860
TNFRSF25 agonistic antibody and galectin-9 combination therapy controls herpes simplex virus-induced immunoinflammatory lesions
description
2012 nî lūn-bûn
@nan
2012 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2012 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
name
TNFRSF25 agonistic antibody an ...... ced immunoinflammatory lesions
@ast
TNFRSF25 agonistic antibody an ...... ced immunoinflammatory lesions
@en
TNFRSF25 agonistic antibody an ...... ced immunoinflammatory lesions
@nl
type
label
TNFRSF25 agonistic antibody an ...... ced immunoinflammatory lesions
@ast
TNFRSF25 agonistic antibody an ...... ced immunoinflammatory lesions
@en
TNFRSF25 agonistic antibody an ...... ced immunoinflammatory lesions
@nl
prefLabel
TNFRSF25 agonistic antibody an ...... ced immunoinflammatory lesions
@ast
TNFRSF25 agonistic antibody an ...... ced immunoinflammatory lesions
@en
TNFRSF25 agonistic antibody an ...... ced immunoinflammatory lesions
@nl
P2093
P2860
P356
P1433
P1476
TNFRSF25 agonistic antibody an ...... ced immunoinflammatory lesions
@en
P2093
Amol Suryawanshi
Barry T Rouse
Eckhard R Podack
Mitsuomi Hirashima
Naveen K Rajasagi
Pradeep B J Reddy
Sachin Mulik
Taylor H Schreiber
Toshiro Niki
P2860
P304
P356
10.1128/JVI.01391-12
P407
P577
2012-10-01T00:00:00Z